MedTrace Logo

MIP Versus PCNL for Kidney Stone Disease

NCT04767919 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 75

Last updated 2025-03-27

No results posted yet for this study

Summary

The decision to use standard percutaneous nephrolithotomy (PCNL) versus mini-percutaneous nephrolithotomy (MIP) has been a subject of much debate in the urological community. The investigators propose a randomized controlled trial to compare the operative outcomes and complications of mini-percutaneous nephrolithotomy (mini-PCNL) versus standard PCNL for renal stones. The results of this study will help guide the decision making regarding these two procedures in the US population and provide further insight into the utility and safety of these procedures. A cost analysis will be performed, and it is hypothesized that the reusable components of the Storz MIP set will result in lower costs of the mini-PCNL procedure compared to standard PCNL.

Conditions

  • Kidney Stone

Interventions

PROCEDURE

Standard Percutaneous Nephrolithotomy (sPCNL)

Endoscopic stone procedure using a laser placed in the kidney through an 30 Fr access sheath following balloon dilation.

PROCEDURE

Minimally Invasive Percutaneous Nephrolithotomy (MIP)

Endoscopic stone procedure using a laser placed in the kidney through an 18 Fr access sheath following either balloon dilation or dilation using a single step metal dilator.

Sponsors & Collaborators

Principal Investigators

  • Manoj Monga, M.D. · UCSD Medical Center, San Diego

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
SINGLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2021-01-01
Primary Completion
2024-06-07
Completion
2024-06-07

Countries

  • United States
  • Canada

Study Locations

More Related Trials

Entities

Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04767919 on ClinicalTrials.gov